Not a good buy right now at ~$19.98 pre-market: Wall St. price targets ($15 Sell from Goldman, $18 Neutral from UBS) sit BELOW the current price, implying limited upside and meaningful downside.
Near-term odds skew negative: pattern stats suggest ~-2.74% next day and ~-1.54% next week (despite a better 1-month view).
Fundamentals are currently deteriorating (sharp YoY profit/EPS drop), and a notable holder (PING Capital) reduced exposure.
Trend/structure: Bullish moving averages (SMA_5 > SMA_20 > SMA_200) suggests the broader trend is still up.
Momentum: MACD histogram is positive (0.0903) but contracting, hinting bullish momentum is weakening.
RSI(6)=58.39: neutral-to-slightly-bullish; not overbought, but not a strong “buy-now” trigger either.
Key levels: Pivot 19.462 (price is slightly above—near-term support). Resistance at R1 21.04; supports at S1 17.885 and S2 16.91.
Quant/pattern read: high probability of short-term drift lower (next day/week) even if the 1-month expectation is positive.
Options Data
Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio
Positioning: Put/Call OI ratio 0.63 is net-bullish positioning (more call OI than puts).
Flow today is more defensive: Put/Call volume ratio 1.5 indicates heavier put trading activity (short-term hedging/bearish tilt).
Volatility: IV (30d) ~96.45 with IV percentile ~90.4 → options are pricing big moves/uncertainty; sentiment is cautious and event-risk aware.
Liquidity/activity: Today’s volume (611) is elevated vs recent 5–10D averages, reinforcing “risk-on/risk-off” churn rather than clean bullish conviction.
Technical Summary
Sell
5
Buy
7
Positive Catalysts
could reset expectations if results surprise to the upside.
Neutral/Negative Catalysts
Analysts are not supportive at current levels: Goldman Sachs = Sell PT $15; UBS = Neutral PT $18 (both below spot ~20).
Recent quarter profitability deterioration: company reported Q3 net income down ~70.9% YoY (and snapshot shows net income/EPS down ~75%+ YoY).
Institutional sentiment headwind: PING Capital reduced BBAR by 269.6k shares ($3.87M) as part of emerging-market risk management.
Short-term statistical edge is negative (expected weakness next day/week).
Elevated implied volatility signals higher uncertainty and can pressure multiples if results/macro disappoint.
Net income: 26,378,422.76, -75.11% YoY (major profitability drop).
EPS: 0.04, -76.47% YoY (earnings power weakened sharply).
Takeaway: growth trends are negative and provide weak support for buying aggressively “right now.”
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent coverage changes skew cautious-to-bearish:
[2025-11-10] Goldman Sachs initiated Sell, PT $15 (concerns around profitability improvement vs peers; lower Tier 1 and higher loan exposure).
[2025-11-19] UBS initiated Neutral, PT $18 (sector at inflection point, but UBS takes a conservative stance).
Wall Street pros view (pros/cons):
Pros: potential sector/macroeconomic inflection in Argentina could improve banking profitability conditions.
Cons: BBAR seen as weaker vs peers on profitability/capital considerations; combined PTs imply the stock is already ahead of fundamentals at ~$20.
Wall Street analysts forecast BBAR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BBAR is 16 USD with a low forecast of 15 USD and a high forecast of 18 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
Wall Street analysts forecast BBAR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BBAR is 16 USD with a low forecast of 15 USD and a high forecast of 18 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
1 Hold
1 Sell
Hold
Current: 17.170
Low
15
Averages
16
High
18
Current: 17.170
Low
15
Averages
16
High
18
UBS
Neutral
initiated
$18
AI Analysis
2025-11-19
Reason
UBS
Price Target
$18
AI Analysis
2025-11-19
initiated
Neutral
Reason
UBS initiated coverage of Banco BBVA Argentina with a Neutral rating and $18 price target. The firm believes the Argentine banking sector is at an "inflection point" after years of inflation, tight capital controls, and negative real interest rates. UBS is taking a "somewhat conservative approach" on the group, putting its only Buy rating on Banco Macro due to its better capital position, "resilient" franchise and potentially lower credit quality risk.
Goldman Sachs
Sell
initiated
$15
2025-11-10
Reason
Goldman Sachs
Price Target
$15
2025-11-10
initiated
Sell
Reason
Goldman Sachs initiated coverage of Banco BBVA Argentina with a Sell rating and $15 price target. The firm believes the bank is in a weaker position to improve its profitability relative to peers. BBVA has the lowest Tier 1 ratio at 18% and it already has more exposure to loans, the analyst tells investors in a research note. Goldman is taking a more balanced view on the group following the share rallies on lower inflation and better economic growth.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BBAR
